About 100 reports

  • Gastrointestinal Drugs Market Characteristics
  • Gastrointestinal Drugs Market Segmentation

Table ##: Global Gastrointestinal Drugs Market, Historic Market Size, 2013-2017, $ Billion Gastrointestinal Drugs Market Forecast Growth The chart and table below shows the year-on-year growth of the global gastrointestinal drugs market during 2017 - 2021.

  • Gastrointestinal Drug
  • World
  • Market Size
  • Allergan plc
  • Novo Nordisk Group

Gastrointestinal Drugs Global Market Report 2019 ##.

  • Gastrointestinal Drug
  • OTC
  • Pharmaceutical
  • Market Size
  • GASTROINTESTINAL DISORDERS, GLOBAL, KEY MARKETED PRODUCTS AND APPROVED INDICATIONS, 2016
  • GASTROINTESTINAL THERAPEUTICS MARKET, GLOBAL, CLINICAL PROGRAM SIZE BY STAGE OF DEVELOPMENT AND INDICATION (PARTICIPANTS), 2006-2016

Alexion only markets one product in the gastrointestinal therapy area, namely Soliris.

  • Gastrointestinal Drug
  • Market Size
  • AbbVie Inc.
  • AstraZeneca PLC
  • Takeda Pharmaceutical Company Limited

Segments Covered ##) Global Gastrointestinal Drugs market a.

  • Gastrointestinal Drug
  • OTC
  • World
  • Market Size

The gastrointestinal market is one of the key therapeutic areas most significantly affected by the generic erosion of block-busters.

  • Gastrointestinal Drug
  • OTC
  • World
  • 07. Epidemiology of Gastrointestinal Disorders
  • GLOBAL GASTROINTESTINAL OTC DRUGS MARKET BY THERAPEUTIC CLASS OF DRUG

Diarrhea is one of the leading gastrointestinal disorders more prevalent in developing countries.

  • Gastrointestinal Drug
  • World
  • GlaxoSmithKline plc
  • Perrigo Company
  • Pfizer Inc.
  • ABBREVIATIONS

Patients will be randomized (##:##) to MSB-## or placebo for one week.

  • Dermatological Condition
  • Gastrointestinal Drug
  • Therapy
  • United States
  • Synthetic Biologics
  • Zantac
  • Market trends

Safe if provided warnings are followed ##.

  • Gastrointestinal Drug
  • AstraZeneca PLC
  • Eisai Co., Ltd.
  • Johnson & Johnson
  • Takeda Pharmaceutical Company Limited
  • Market definition
  • EMEA - MARKET SIZE AND FORECAST 2017-2022

You can easily book an appointment with one online.

  • Gastrointestinal Drug
  • Bayer AG
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • SAFETY OF LOTRONEX - MOST FREQUENTLY REPORTED AES
  • PRODUCT PROFILE - SYN-010

Our Gastrointestinal Portfolio.

  • Gastrointestinal Drug
  • Allergan plc
  • Ardelyx, Inc.
  • Astellas Pharma Inc.
  • Ironwood Pharmaceuticals, Inc.
  • 2. H2 RECEPTOR ANTAGONISTS
  • Digestive Remedies Market Overview

The demand for Bismuth preparation is limited due to its poor taste. (##)Sucralfate is an oral gastrointestinal medication primarily indicated for the treatment of active duodenal ulcers.

  • Gastrointestinal Drug
  • China
  • Demand
  • Trade
  • AstraZeneca PLC
  • CHAPTER IV DIGESTIVE REMEDIES DRUGS PRODUCTION AND DEMAND

The demand for Bismuth preparation is limited due to its poor taste. (##)Sucralfate is an oral gastrointestinal medication primarily indicated for the treatment of active duodenal ulcers.

  • Gastrointestinal Drug
  • China
  • Demand
  • AstraZeneca PLC
  • Xian-Janssen Pharmaceutical Ltd.
  • Irritable Bowel Syndrome: Executive Summary
  • 3.1 DISEASE BACKGROUND

Gut and Liver; ##(##):##-##.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • OTC
  • Italy
  • Forecast
  • Other gastrointestinal disease, total (000s)
  • IBS patients with gastroenteritis, total (000s)

Other gastrointestinal disease, total (##s) Table ##.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • OTC
  • Pathology
  • Italy
  • Regional Sales of Gluten-Free Food 2012/2017/2022
  • Digestive Remedies Sales by Region: 2012/2017/2022

Japan and South Korea saw declines in sales over the same time period, with CAGRs of -##% and - ##%, respectively, while India only saw an increase of ##% over that time.

  • Gastrointestinal Drug
  • Demand
  • Bayer AG
  • Pfizer Inc.
  • Sanofi S.A.

They have sixty plus products on market, covering categories of gastrointestinal, cardiovascular, anti-tumor, and antibiotics.

  • Gastrointestinal Drug
  • China
  • Supply
  • Shandong Xinhua Pharmaceutical Company Limited
  • Tianjin Pharmaceutical Co., Ltd.

FOLLOWED TYPES ARE THE GASTROINTESTINAL TRACT TYPE, SKIN TYPE OTC DRUGS.

  • Gastrointestinal Drug
  • China
  • Demand
  • Supply
  • Shandong Xinhua Pharmaceutical Company Limited

The auto exports exceeded over ## million each year.

  • Gastrointestinal Drug
  • China
  • Demand
  • AstraZeneca China Inc.
  • Eisai Co., Ltd.

Some of the prominent trends that the market is witnessing include occurrence of serious health issues with excessive usage of saline laxative, growing incidence of gastrointestinal diseases, recent technological developments of Saline Laxative and growth opportunities/ investment oppor

  • Gastrointestinal Drug
  • APAC
  • North America
  • World
  • Forecast

They have sixty plus products on market, covering categories of gastrointestinal, cardiovascular, anti-tumor, and antibiotics.

  • Gastrointestinal Drug
  • China
  • Demand
  • AstraZeneca PLC
  • Xian-Janssen Pharmaceutical Ltd.

IBS is one of the most common gastrointestinal disorders.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Molecular Diagnostics
  • Pathology
  • Therapy

There are many small producers whose capacity is below one billion yuan.

  • Gastrointestinal Drug
  • AstraZeneca China Inc.
  • Eisai Co., Ltd.
  • Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
  • Nanjing Aosaikang Medicinal Group
  • DIGESTIVE REMEDIES IN THE US - CATEGORY ANALYSIS

Stress can cause and exacerbate numerous digestive disorders, including nausea, indigestion and heartburn, as well as general gastrointestinal upset.

  • Gastrointestinal Drug
  • Ophthalmic Solution
  • OTC
  • United States
  • Demand

The report provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/ IND, pre registration, phase ##, phase ##, and phase ## trials).

  • Digestive System Disorder
  • Gastrointestinal Drug
  • OTC
  • Pathology
  • Pharmaceutical
  • Gastrointestinal Drugs
  • Six: Gastrointestinal Drugs

Chapter Six: Gastrointestinal Drugs Figure ##-## U. S.

  • Gastrointestinal Drug
  • United States
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.

The rising pervasiveness of gastrointestinal infections and confusion, the geriatric populace, undesirable eating regimen, uneasiness, depression, and changing way of life in the Americas are the key drivers of the Americas IBS market.

  • Gastrointestinal Drug
  • North America
  • South America
  • United States
  • Market Size

Constipation is a common functional gastrointestinal (GI) disorder that is most prevalent in the elderly and female population.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pathology

GASTROINTESTINAL (GI) DISORDERS ##. ##. ##.

  • Gastrointestinal Drug
  • North America
  • United States
  • Market Size
  • MicroBiome Therapeutics LLC

GERD is one of the commonly observed recurrent gastrointestinal disorders worldwide.

  • Gastrointestinal Drug
  • OTC
  • Therapy
  • United States
  • Market Size

GERD is one of the regularly watched intermittent gastrointestinal disorders around the world.

  • Gastrointestinal Drug
  • North America
  • South America
  • United States
  • Market Size